Research Society

 
News Articles for Research Society top ^
Employees to hold fundraisers at more than 100 airports in addition to jet aircraft drag competition ATLANTA , May 1, 2014 /PRNewswire/ -- Delta Air Lines (NYSE: DAL) will hold more than 100 fundraising events next week as part of its partnership with the American Cancer Society with a new goal to generate $1.3 million to support research and other endeavors to end cancer.
Sign-up for Delta Air Lines Partners with American Cancer Society to Achieve $1.3 million in Fundraising to End Cancer investment picks
HAIFA, Israel, April 16, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that Dr.
Sign-up for Pluristem to Deliver Key Commercialization and Scientific Presentations at International Society for Cellular Therapy Conference 2014 investment picks
SAN DIEGO , April 22, 2014 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI) , a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced two abstracts to be presented at the Annual Meeting of the American Society of Clinical Oncology, held May 30 through June 3, 2014 , at McCormick Place in Chicago .
Sign-up for Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology investment picks
VANCOUVER, British Columbia, May 14, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP) , a clinical stage pharmaceutical company discovering and developing targeted therapeutics for inflammatory disease and cancer, today announced that the company will present a "study in progress" poster on the FLAGSHIP trial of its lead development candidate, AQX-1125, at the 2014 American Thoracic Society (ATS) International Conference.
Sign-up for Corrected - Aquinox Pharmaceuticals Announces Presentation on FLAGSHIP Study at the 2014 American Thoracic Society International Conference investment picks
VANCOUVER, British Columbia, May 14, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP) , a clinical stage pharmaceutical company discovering and developing targeted therapeutics for inflammatory disease and cancer, today announced that the company will present a "study in progress" poster on the FLAGSHIP trial of its lead development candidate, AQX-1125, at the 2014 American Thoracic Society (ATS) International Conference.
Sign-up for Aquinox Pharmaceuticals Announces Presentation on FLAGSHIP Study at the 2014 American Thoracic Society International Conference investment picks
SAN DIEGO , May 14, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV) , a developer of cell-free molecular diagnostics, today announced that data from a study of its precision cancer monitoring technology, conducted by MD Anderson Cancer Center and Memorial Sloan-Kettering Cancer Center, will be presented during a poster session at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO). An additional abstract, submitted by Filip Janku , M.D., Ph.D., of The University of Texas MD Anderson Cancer, has been accepted for publication in 2014 ASCO Annual Meeting Proceedings , a Journal of Clinical Oncology.
Sign-up for Trovagene Announces Data Presentations, Published Abstracts at Annual Meeting of American Society of Clinical Oncology investment picks
MENLO PARK, Calif., May 14, 2014 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio ® RS II system, announced today that its Single Molecule, Real-Time (SMRT ® ) DNA Sequencing technology will be featured in seven podium and 13 poster presentations at the 2014 American Society for Microbiology (ASM) annual meeting in Boston.
Sign-up for Single Molecule, Real-Time (SMRT) DNA Sequencing Technology From Pacific Biosciences to be Featured in 20 Presentations at the American Society for Microbiology 2014 Annual Meeting investment picks
PORTLAND, Ore., May 21, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE) , a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that data from the Company's Phase 1 study with GALE-301, or Folate Binding Protein, will be presented at the upcoming American Society of Clinical Oncology (ASCO) 50 th Annual Meeting.
Sign-up for Galena Biopharma to Present GALE-301 Phase 1 Data at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting investment picks
2014/4/22
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G014779-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/4/21/11G014779/Scotiabank-logo-780364326799.jpg TORONTO, ON--(Marketwired - April 22, 2014) - One-in-five Canadians with a written will (22%) plan to leave some of their estate to charity, with the primary reason to give back to society (60%), according to Scotiabank's annual Investment Poll.
Sign-up for One-in-Five Canadians Leaving Some of Their Estate to Charity; Want to Give Back to Society: Scotiabank Poll investment picks
The Tomcat instrument streamlines laboratory workflow by providing automated processing of liquid-based cytology samples BEDFORD, Mass.
Sign-up for Hologic's New Tomcat Pre-analytical Sample Processing Instrument to be Featured at the American Society for Microbiology General Meeting investment picks
EDEN PRAIRIE, Minn., May 14, 2014 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) today announced that Dr.
Sign-up for Sunshine Heart Announces Presentations at the Annual Meeting of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) investment picks
NEW YORK, April 30, 2014 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI) , a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that several presentations related to ITI-007, the Company's lead product candidate, will be featured at the following meetings: APA Presentations Jeffrey A.
Sign-up for Intra-Cellular Therapies Announces Upcoming Presentations on ITI-007 at the American Psychiatric Association 167th Annual Meeting, the Society of Biological Psychiatry 69th Annual Meeting, and the International Review of Psychosis & Bipolarity Annual Meeting investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Research Society
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Site  |  Next: Research Solutions